上 EVZVXEgDGjZu 298158
Estimated solely for the purpose of calculating the filing fee pursuant to Rule 011 of the Securities Exchange Act of 1934, as amended, based on based on (a) the product of (i) $435, the average of the high and low sales prices per share of YuMe, Inc ("YuMe") common stock on December 28, 17, as reported by the New York Stock Exchange, and (ii) 35,804,666, the estimated number of YuMeTxt hdrsgml accession number conformed submission type 8k public document count 17 conformed period of report item information financial statements and exhibits filed as of date date as of change filer company data company conformed name oplinkTxt hdrsgml accession number conformed submission type 8k public document count 41 conformed period of report item information results of operations and financial condition item information financial statements and exhibits filed as of date date as of change
Eƒ Ae A A ˆa E Sa A A Ae A C Aœ E œas Ae E Az A A A Ae C
"EV"ZVXEgDGjZu"
"EV"ZVXEgDGjZu"-Revance Therapeutics, Inc 7555 Gateway Boulevard Newark, California (Address of principal executive offices and zip code) Registrant's telephone number, including area code (510) Check the appropriate box below if the Form 8K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General InstructionUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 549 FORM 8K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Eƒ Ae A A ˆa E Sa A A Ae A C Aœ E œas Ae E Az A A A Ae C
David C Karp Ronald C Chen Wachtell, Lipton, Rosen & Katz 51 West 52nd Street New York, New York (212) Seth R Weissman Phuong Y PhillipsTxt hdrsgml accession number conformed submission type 8k public document count 3 conformed period of report 1409 item information regulation fd disclosure item information financial statements and exhibits filed as of date date as of change filer company data


Eƒ Ae A A ˆa E Sa A A Ae A C Aœ E œas Ae E Az A A A Ae C


Ae A Ae Aœ Ae E Az A A A Ae C


コメント
コメントを投稿